These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 31948289)

  • 1. Short chain fatty acids and methylamines produced by gut microbiota as mediators and markers in the circulatory system.
    Onyszkiewicz M; Jaworska K; Ufnal M
    Exp Biol Med (Maywood); 2020 Jan; 245(2):166-175. PubMed ID: 31948289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO.
    Poll BG; Cheema MU; Pluznick JL
    Physiology (Bethesda); 2020 Jul; 35(4):275-284. PubMed ID: 32490748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between gut microbiome and cardiovascular disease.
    Peng J; Xiao X; Hu M; Zhang X
    Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous HS-SPME GC-MS determination of short chain fatty acids, trimethylamine and trimethylamine N-oxide for gut microbiota metabolic profile.
    Fiori J; Turroni S; Candela M; Brigidi P; Gotti R
    Talanta; 2018 Nov; 189():573-578. PubMed ID: 30086962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Gut Microbiota and Associated Compounds in Cardiovascular Health and its Therapeutic Implications.
    Liu L; Kaur GI; Kumar A; Kanwal A; Singh SP
    Cardiovasc Hematol Agents Med Chem; 2024; 22(3):375-389. PubMed ID: 38275032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting on Gut Microbial Metabolite Trimethylamine-N-Oxide and Short-Chain Fatty Acid to Prevent Maternal High-Fructose-Diet-Induced Developmental Programming of Hypertension in Adult Male Offspring.
    Hsu CN; Chang-Chien GP; Lin S; Hou CY; Tain YL
    Mol Nutr Food Res; 2019 Sep; 63(18):e1900073. PubMed ID: 31295767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota in Hypertension and Atherosclerosis: A Review.
    Verhaar BJH; Prodan A; Nieuwdorp M; Muller M
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota and microbiota-derived metabolites in cardiovascular diseases.
    Chen X; Zhang H; Ren S; Ding Y; Remex NS; Bhuiyan MS; Qu J; Tang X
    Chin Med J (Engl); 2023 Oct; 136(19):2269-2284. PubMed ID: 37442759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota and Cardiovascular Disease.
    Witkowski M; Weeks TL; Hazen SL
    Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiome metabolite quantification methods enabling insights into human health and disease.
    Roach J; Mital R; Haffner JJ; Colwell N; Coats R; Palacios HM; Liu Z; Godinho JLP; Ness M; Peramuna T; McCall LI
    Methods; 2024 Feb; 222():81-99. PubMed ID: 38185226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota-derived metabolites as central regulators in metabolic disorders.
    Agus A; Clément K; Sokol H
    Gut; 2021 Jun; 70(6):1174-1182. PubMed ID: 33272977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-talk between gut microbiome, salt and hypertension.
    Naqvi S; Asar TO; Kumar V; Al-Abbasi FA; Alhayyani S; Kamal MA; Anwar F
    Biomed Pharmacother; 2021 Feb; 134():111156. PubMed ID: 33401080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble Dietary Fiber Reduces Trimethylamine Metabolism via Gut Microbiota and Co-Regulates Host AMPK Pathways.
    Li Q; Wu T; Liu R; Zhang M; Wang R
    Mol Nutr Food Res; 2017 Dec; 61(12):. PubMed ID: 28884952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota.
    Hoyles L; Jiménez-Pranteda ML; Chilloux J; Brial F; Myridakis A; Aranias T; Magnan C; Gibson GR; Sanderson JD; Nicholson JK; Gauguier D; McCartney AL; Dumas ME
    Microbiome; 2018 Apr; 6(1):73. PubMed ID: 29678198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of Gut Microbiota in Cardiovascular Diseases.
    Zhou W; Cheng Y; Zhu P; Nasser MI; Zhang X; Zhao M
    Oxid Med Cell Longev; 2020; 2020():5394096. PubMed ID: 33062141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microbiome and its pharmacological targets: therapeutic avenues in cardiometabolic diseases.
    Neves AL; Chilloux J; Sarafian MH; Rahim MB; Boulangé CL; Dumas ME
    Curr Opin Pharmacol; 2015 Dec; 25():36-44. PubMed ID: 26531326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism.
    Morrison DJ; Preston T
    Gut Microbes; 2016 May; 7(3):189-200. PubMed ID: 26963409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying mass spectrometry-based assays to explore gut microbial metabolism and associations with disease.
    Heaney LM
    Clin Chem Lab Med; 2020 Apr; 58(5):719-732. PubMed ID: 31639103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review.
    Duttaroy AK
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33401598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding connections and roles of gut microbiome in cardiovascular diseases.
    Rajendiran E; Ramadass B; Ramprasath V
    Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.